Advanced search
Publication Cover
Acta Oncologica Volume 57, 2018 - Issue 4
Journal homepage
2,585
Views
35
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: COLORECTAL CANCER

Tumor–stroma ratio predicts recurrence in patients with colon cancer treated with neoadjuvant chemotherapy

Torben Frøstrup HansenDanish Colorectal Cancer Center South, Vejle Hospital, Vejle, Denmark; ;Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark; Correspondence[email protected] [email protected]
View further author information
,
Sanne Kjær-FrifeldtDanish Colorectal Cancer Center South, Vejle Hospital, Vejle, Denmark; ;Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark; View further author information
,
Jan LindebjergDanish Colorectal Cancer Center South, Vejle Hospital, Vejle, Denmark; ;Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark; View further author information
,
Søren Rafael RafaelsenDanish Colorectal Cancer Center South, Vejle Hospital, Vejle, Denmark; ;Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark; View further author information
,
Lars Henrik JensenDanish Colorectal Cancer Center South, Vejle Hospital, Vejle, Denmark; ;Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark; View further author information
,
Anders JakobsenDanish Colorectal Cancer Center South, Vejle Hospital, Vejle, Denmark; ;Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark; View further author information
&
Flemming Brandt SørensenDanish Colorectal Cancer Center South, Vejle Hospital, Vejle, Denmark; ;Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark; ;University Institute of Pathology, Aarhus University Hospital, Aarhus, DenmarkView further author information
 show all
Pages 528-533 | Received 23 Jun 2017, Accepted 21 Sep 2017, Published online: 05 Oct 2017

References

  • Bockelman C, Engelmann BE, Kaprio T, et al. Risk of recurrence in patients with colon cancer stage II and III: a systematic review and meta-analysis of recent literature. Acta Oncol. 2015;54:5–16.
  • O'Connor ES, Greenblatt DY, LoConte NK, et al. Adjuvant chemotherapy for stage II colon cancer with poor prognostic features. J Clin Oncol. 2011;29:3381–3388.
  • Labianca R, Nordlinger B, Beretta GD, et al. Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24:64–72.
  • Pelt GW, Hansen TF, Bastiaannet E, et al. Stroma-high lymph node involvement predicts poor survival more accurately for patients with stage III colon cancer. J Med Surg Pathol. 2016;1:116. doi:10.4172/jmsp.1000116.
  • Vogelaar FJ, Pelt GW, van Leeuwen AM, et al. Are disseminated tumor cells in bone marrow and tumor–stroma ratio clinically applicable for patients undergoing surgical resection of primary colorectal cancer? The Leiden MRD study. Cell Oncol. 2016;39:537–544.
  • Park JH, Richards CH, McMillan DC, et al. The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer. Ann Oncol. 2014;25:644–651.
  • Huijbers A, Tollenaar RA, Pelt GW, et al. The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial. Ann Oncol. 2013;24:179–185.
  • West NP, Dattani M, McShane P, et al. The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients. Br J Cancer. 2010;102:1519–1523.
  • Mesker WE, Liefers GJ, Junggeburt JM, et al. Presence of a high amount of stroma and downregulation of SMAD4 predict for worse survival for stage I–II colon cancer patients. Cell Oncol. 2009;31:169–178.
  • Mesker WE, Junggeburt JM, Szuhai K, et al. The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage. Cell Oncol. 2007;29:387–398.
  • Foxtrot Collaborative Group. Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial. Lancet Oncol. 2012;13:1152–1160.
  • Jakobsen A, Andersen F, Fischer A, et al. Neoadjuvant chemotherapy in locally advanced colon cancer. A phase II trial. Acta Oncol. 2015;54:1747–1753.
  • McShane LM, Altman DG, Sauerbrei W, et al. REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer. 2005;93:387–391.
  • Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer. 1994;73:2680–2686.
  • Lambert A, Pattabiraman DR, Weinberg RA. Emerging biological principles of metastasis. Cell. 2017;168:670–691.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.